Glucose Metabolic Reprogramming in Autoimmune Diseases

Overview

Journal Anim Cells Syst (Seoul)

Specialty Biology

Date 2023 Jul 19

PMID 37465289

Authors

Hoim Jeong

Beomgu Lee

Seung Jin Han

Dong Hyun Sohn

Affiliations

Soon will be listed here.

Abstract

Autoimmune diseases are conditions in which the immune system mistakenly targets and damages healthy tissue in the body. In recent decades, the incidence of autoimmune diseases has increased, resulting in a significant disease burden. The current autoimmune therapies focus on targeting inflammation or inducing immunosuppression rather than addressing the underlying cause of the diseases. The activity of metabolic pathways is elevated in autoimmune diseases, and metabolic changes are increasingly recognized as important pathogenic processes underlying these. Therefore, metabolically targeted therapies may represent an important strategy for treating autoimmune diseases. This review provides a comprehensive overview of the evidence surrounding glucose metabolic reprogramming and its potential applications in drug discovery and development for autoimmune diseases, such as type 1 diabetes, multiple sclerosis, systemic lupus erythematosus, rheumatoid arthritis, and systemic sclerosis.

Citing Articles

Isoacteoside alleviates hepatocellular carcinoma progression by inhibiting PDHB-mediated reprogramming of glucose metabolism.

Zhao L, Qi H, Liu W, Lv H, Li P, Liu W Commun Biol. 2025; 8(1):205.

PMID: 39922943 PMC: 11807089. DOI: 10.1038/s42003-025-07622-x.

From diagnosis to treatment: exploring the mechanisms underlying optic neuritis in multiple sclerosis.

Tong B, Zhang X, Hu H, Yang H, Wang X, Zhong M J Transl Med. 2025; 23(1):87.

PMID: 39838397 PMC: 11748848. DOI: 10.1186/s12967-025-06105-1.

Advances in modeling cellular state dynamics: integrating omics data and predictive techniques.

Jung S Anim Cells Syst (Seoul). 2025; 29(1):72-83.

PMID: 39807350 PMC: 11727055. DOI: 10.1080/19768354.2024.2449518.

Unraveling the immunometabolism puzzle: Deciphering systemic sclerosis pathogenesis.

Masoumi M, Bodaghi A, Khorramdelazad H, Ebadi E, Houshmandfar S, Saeedi-Boroujeni A Heliyon. 2024; 10(15):e35445.

PMID: 39170585 PMC: 11336762. DOI: 10.1016/j.heliyon.2024.e35445.

Effect of RNF113A deficiency on oxidative stress-induced NRF2 pathway.

Cho N, Kim Y, Lee Y, Choi D, Park C, Kim J Anim Cells Syst (Seoul). 2024; 28(1):261-271.

PMID: 38741949 PMC: 11089925. DOI: 10.1080/19768354.2024.2349758.

References

Guijas C, Montenegro-Burke J, Warth B, Spilker M, Siuzdak G . Metabolomics activity screening for identifying metabolites that modulate phenotype. Nat Biotechnol. 2018; 36(4):316-320. PMC: 5937131. DOI: 10.1038/nbt.4101. View

Biniecka M, Canavan M, McGarry T, Gao W, McCormick J, Cregan S . Dysregulated bioenergetics: a key regulator of joint inflammation. Ann Rheum Dis. 2016; 75(12):2192-2200. PMC: 5136702. DOI: 10.1136/annrheumdis-2015-208476. View

Streeter H, Wraith D . Manipulating antigen presentation for antigen-specific immunotherapy of autoimmune diseases. Curr Opin Immunol. 2021; 70:75-81. PMC: 8376632. DOI: 10.1016/j.coi.2021.03.019. View

Noyes K, Weinstock-Guttman B . Impact of diagnosis and early treatment on the course of multiple sclerosis. Am J Manag Care. 2014; 19(17 Suppl):s321-31. View

Burrack A, Martinov T, Fife B . T Cell-Mediated Beta Cell Destruction: Autoimmunity and Alloimmunity in the Context of Type 1 Diabetes. Front Endocrinol (Lausanne). 2017; 8:343. PMC: 5723426. DOI: 10.3389/fendo.2017.00343. View

Kaskow B, Baecher-Allan C . Effector T Cells in Multiple Sclerosis. Cold Spring Harb Perspect Med. 2018; 8(4). PMC: 5880159. DOI: 10.1101/cshperspect.a029025. View

Hanlon M, McGarry T, Marzaioli V, Amaechi S, Song Q, Nagpal S . Rheumatoid arthritis macrophages are primed for inflammation and display bioenergetic and functional alterations. Rheumatology (Oxford). 2022; 62(7):2611-2620. PMC: 10321118. DOI: 10.1093/rheumatology/keac640. View

Chen J, Chernatynskaya A, Li J, Kimbrell M, Cassidy R, Perry D . T cells display mitochondria hyperpolarization in human type 1 diabetes. Sci Rep. 2017; 7(1):10835. PMC: 5589742. DOI: 10.1038/s41598-017-11056-9. View

Hochrein S, Wu H, Eckstein M, Arrigoni L, Herman J, Schumacher F . The glucose transporter GLUT3 controls T helper 17 cell responses through glycolytic-epigenetic reprogramming. Cell Metab. 2022; 34(4):516-532.e11. PMC: 9019065. DOI: 10.1016/j.cmet.2022.02.015. View

10.

Koju N, Qin Z, Sheng R . Reduced nicotinamide adenine dinucleotide phosphate in redox balance and diseases: a friend or foe?. Acta Pharmacol Sin. 2022; 43(8):1889-1904. PMC: 9343382. DOI: 10.1038/s41401-021-00838-7. View

11.

Patra K, Hay N . The pentose phosphate pathway and cancer. Trends Biochem Sci. 2014; 39(8):347-54. PMC: 4329227. DOI: 10.1016/j.tibs.2014.06.005. View

12.

Martins C, New L, OConnor E, Previte D, Cargill K, Tse I . Glycolysis Inhibition Induces Functional and Metabolic Exhaustion of CD4 T Cells in Type 1 Diabetes. Front Immunol. 2021; 12:669456. PMC: 8216385. DOI: 10.3389/fimmu.2021.669456. View

13.

Kottmann R, Kulkarni A, Smolnycki K, Lyda E, Dahanayake T, Salibi R . Lactic acid is elevated in idiopathic pulmonary fibrosis and induces myofibroblast differentiation via pH-dependent activation of transforming growth factor-β. Am J Respir Crit Care Med. 2012; 186(8):740-51. PMC: 3480515. DOI: 10.1164/rccm.201201-0084OC. View

14.

Tsokos G . Systemic lupus erythematosus. N Engl J Med. 2011; 365(22):2110-21. DOI: 10.1056/NEJMra1100359. View

15.

Yin Y, Choi S, Xu Z, Zeumer L, Kanda N, Croker B . Glucose Oxidation Is Critical for CD4+ T Cell Activation in a Mouse Model of Systemic Lupus Erythematosus. J Immunol. 2015; 196(1):80-90. PMC: 4684991. DOI: 10.4049/jimmunol.1501537. View

16.

Okano T, Saegusa J, Nishimura K, Takahashi S, Sendo S, Ueda Y . 3-bromopyruvate ameliorate autoimmune arthritis by modulating Th17/Treg cell differentiation and suppressing dendritic cell activation. Sci Rep. 2017; 7:42412. PMC: 5301239. DOI: 10.1038/srep42412. View

17.

He L . Metformin and Systemic Metabolism. Trends Pharmacol Sci. 2020; 41(11):868-881. PMC: 7572679. DOI: 10.1016/j.tips.2020.09.001. View

18.

Wang L, Wang F, Gershwin M . Human autoimmune diseases: a comprehensive update. J Intern Med. 2015; 278(4):369-95. DOI: 10.1111/joim.12395. View

19.

Shyer J, Flavell R, Bailis W . Metabolic signaling in T cells. Cell Res. 2020; 30(8):649-659. PMC: 7395146. DOI: 10.1038/s41422-020-0379-5. View

20.

Masoumi M, Mehrabzadeh M, Mahmoudzehi S, Mousavi M, Jamalzehi S, Sahebkar A . Role of glucose metabolism in aggressive phenotype of fibroblast-like synoviocytes: Latest evidence and therapeutic approaches in rheumatoid arthritis. Int Immunopharmacol. 2020; 89(Pt A):107064. DOI: 10.1016/j.intimp.2020.107064. View